OR
Showing 26 - 50 of >10,000
Cerebral Aneurysm Trial in Roma (Endovascular embolization or surgery)
Recruiting
- Cerebral Aneurysm
- Endovascular embolization or surgery
-
Roma, RM, ItalyFondazione Policlinico Universitario A.Gemelli IRCCS
Feb 6, 2023
NHWD-870 in Advanced Solid Tumors or Lymphomas Carrying NUT
Recruiting
- Advanced Solid Tumors or Lymphomas
-
Changsha, Hunan, ChinaHunan Provincal Tumor Hospital
Oct 5, 2023
Squamous Cell Carcinoma Trial (MK-3475A)
Not yet recruiting
- Squamous Cell Carcinoma
- MK-3475A
- (no location specified)
Sep 11, 2023
Carcinoma, Hepatocellular Trial (Atezolizumab, Bevacizumab, Tiragolumab)
Not yet recruiting
- Carcinoma, Hepatocellular
- Atezolizumab
- +3 more
- (no location specified)
Jun 14, 2023
Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe
Not yet recruiting
- Primary Hypercholesterolemia
- Mixed Dyslipidemia
- Bempedoic acid and/or its fixed dose combination with ezetimibe
- (no location specified)
Mar 23, 2023
DMEK Endothelial Keratoplasty inHistory of Anterior or Posterior
Not yet recruiting
- Patients Undergoing DMEK With a History of Anterior or Posterior Segment Surgery
- Descemet Membrane Endothelial Keratoplasty
- (no location specified)
Aug 22, 2023
Relapsed or Refractory Multiple Myeloma Trial (Forimtamig, Carfilzomib, Daratumumab)
Not yet recruiting
- Relapsed or Refractory Multiple Myeloma
- Forimtamig
- +2 more
- (no location specified)
Sep 20, 2023
MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers Trial in Kashiwa (HRO761,
Recruiting
- MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers
- HRO761
- +2 more
-
Kashiwa, Chiba, JapanNovartis Investigative Site
May 2, 2023
Gastric, Colorectal Adenocarcinoma Trial in Shenyang (tislelizumab)
Not yet recruiting
- Gastric
- Colorectal Adenocarcinoma
-
Shenyang, Liaoning, ChinaLiaoning Cancer Hospital & Institute
Nov 1, 2023
Adenoid Cystic Carcinoma of the Head and Neck Trial (OBT076, Balstilimab)
Not yet recruiting
- Adenoid Cystic Carcinoma of the Head and Neck
- (no location specified)
Jul 3, 2023
Overweight or Obesity Trial in Shijiazhuang (TG103 22.5 mg, Placebo)
Not yet recruiting
- Overweight or Obesity
- TG103 22.5 mg
- Placebo
-
Shijiazhuang, Hebei, ChinaClinical Trials Information Group
Aug 18, 2023
Colonic Resection or Stoma, or Self-expandable Metallic Stent
Not yet recruiting
- Colon Cancer
- primary tumor resection
- (no location specified)
Apr 11, 2023
Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small
Recruiting
- Relapsed or Refractory CD19+ B-cell Lymphoma
- +2 more
- TBI-2001
- +2 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jul 26, 2023
Chronic Lymphocytic Leukemia, Richter's Transformation Trial in Boston (Glofitamab, Obinutuzumab, Polatuzumab Vedotin)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Richter's Transformation
- Glofitamab
- +4 more
-
Boston, Massachusetts
- +1 more
Sep 12, 2023
Colorectal Carcinoma Trial in Shanghai (QL1706, Bevacizumab, Oxaliplatin injection)
Recruiting
- Colorectal Carcinoma
- QL1706
- +3 more
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Mar 23, 2023
Chemo Induced Nausea and Vomiting Trial in Mount Olive (Akynzeo)
Recruiting
- Chemotherapy Induced Nausea and Vomiting
-
Mount Olive, AlabamaRudolph M Navari
Oct 8, 2023
Cervical Cancer Trial in Chongqing, Fuzhou (TQB2868 injection, Paclitaxel injection, Cisplatin injection)
Not yet recruiting
- Cervical Cancer
- TQB2868 injection
- +4 more
-
Chongqing, Chongqing, China
- +1 more
Aug 17, 2023
Relapsed and/or Refractory Multiple Myeloma Trial in Köln (BMS-986453, Fludarabine, Cyclophosphamide)
Not yet recruiting
- Relapsed and/or Refractory Multiple Myeloma
- BMS-986453
- +2 more
-
Köln, GermanyLocal Institution - 0017
Dec 4, 2023
Hypoxia, Hysteroscopy, Overweight or Obesity Trial in Shanghai (remimazolam, Propofol)
Not yet recruiting
- Hypoxia
- +2 more
-
Shanghai, Pudong New Area, ChinaRenji Hospital
Aug 24, 2023
" Visual Characterization of Parkinson's Patients and Oculomotor
Not yet recruiting
- Parkinson Disease
- Clinical measurements
- Oculomotor or perceptual therapy
- (no location specified)
Sep 13, 2023
Recurrent Vulvar Cancer, Persistent Vulvar Cancer, Metastatic Vulva Cancer Trial (Pembrolizumab, Lenvatinib)
Not yet recruiting
- Recurrent Vulvar Cancer
- +3 more
- (no location specified)
Jun 12, 2023
Relapsed or Refractory Acute Myeloid Leukemia Trial in Taiyuan (Selinexor, Homoharringtonine, Daunorubicin)
Recruiting
- Relapsed or Refractory Acute Myeloid Leukemia
- Selinexor
- +5 more
-
Taiyuan, Shanxi, ChinaTao Wang
Feb 9, 2023
Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma Trial in San Antonio (WTX-330)
Recruiting
- Advanced or Metastatic Solid Tumors
- Non-Hodgkin Lymphoma
-
San Antonio, TexasNEXT Oncology
Jan 6, 2023